Related Experiment Videos
Nonsurgical treatment evaluation in benign prostatic hyperplasia patients
J M Buzelin1, P Glemain, L Le Normand
1Department of Urology, Hôtel-Dieu, Centre Hospitalier-Universitaire, Nantes, France.
European Urology
|January 1, 1993
Summary
Assessing benign prostatic hyperplasia (BPH) treatments requires careful selection of clinical and urodynamic criteria. The study critically examines these measures, emphasizing functional balance over strict urodynamic performance for effective BPH management.
Area of Science:
- Urology
- Medical Informatics
Background:
- Benign prostatic hyperplasia (BPH) treatment efficacy assessment necessitates reliable evaluation criteria.
- Current methods often involve clinical and urodynamic parameters, each with limitations.
Purpose of the Study:
- To critically evaluate the criteria used for assessing the efficiency of new benign prostatic hyperplasia (BPH) treatments.
- To highlight the importance of functional balance in BPH treatment outcomes.
Main Methods:
- Review of existing clinical and urodynamic assessment methods for BPH.
- Critical analysis of the impact of quantification and statistical processing on the interpretation of symptoms and parameters.
- Focus on the pressure/flow relationship and micturitional bladder pressure as key urodynamic indicators.
Main Results:
- Quantification of clinical symptoms into scores can alter their original meaning.
- Urodynamic parameters, while valuable, have varying reliability in measuring obstruction.
- Statistical analysis of data may also distort the true significance of variables.
Conclusions:
- The primary goal of BPH treatment should be to restore comfortable functional balance for patients.
- Urodynamic performance alone may not be the most critical outcome measure.
- A critical approach to assessment criteria is essential for accurate evaluation of BPH therapies.